13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
SCHEDULE Filed 2025-08-22 Event 2025-08-20 SEC 0000921895-25-002365 →

Radoff Bradley Louis → ENZO BIOCHEM INC

Stake: — Shares: — CUSIP: 294100102 Class: Common Stock, par value $0.01 per share
Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 2/100 · Filer 90d Win Rate: 33% · Hist. 90d Edge: -1.7%
  • Filer track record (3 filings): 33% 90d win rate, +0.0% 90d edge

Item 4 — Purpose of Transaction

Item 4 is hereby amended to add the following: On June 23, 2025, the Issuer entered into an Agreement and Plan of Merger (the "Merger Agreement") with Bethpage Parent, Inc., a Delaware corporation ("Parent"), and Bethpage Merger Sub, Inc., a New York corporation and a wholly owned subsidiary of Parent ("Merger Sub"). On August 20, 2025, pursuant to the terms of the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger") effective as of the effective time of the Merger (the "Effective Time"), with the Issuer continuing as the surviving corporation of the Merger and a wholly owned subsidiary of Parent. At the Effective Time, each Share that was issued and outstanding immediately prior to the Effective Time, subject to certain customary exceptions specified in the Merger Agreement, was automatically converted into the right to receive $0.70 in cash, without interest (the "Merger Consideration")and subject to applicable withholding taxes. In addition, pursuant to the Merger Agreement, at the Effective Time, (i) each Issuer restricted stock unit ("RSU") that was outstanding as of immediately prior to the Effective Time and was either (A) held by a member of the Issuer's board of directors (whether vested or unvested) or (B) vested in accordance with its terms but not yet settled as of the Effective Time (each, a "Vested RSU") was automatically cancelled and converted into the right to receive an amount in cash, without interest, equal to the product obtained by multiplying (A) the total number of Shares underlying such RSU, by (B) the Merger Consideration, subject to applicable withholding taxes, (ii) each RSU that was outstanding as of immediately prior to the Effective Time and not a Vested RSU was automatically canceled without any consideration payable therefor and (iii) each option to purchase Shares that was outstanding as of immediately prior to the Effective Time was automatically canceled without any consideration payable therefor. Accordingly, as a result of the Merger, the Reporting Persons no longer beneficially own any securities of the Issuer.

Cross-References

Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
28 13D/G filings on this issuer
27 other filings besides this one
Filer Track Record
30 filings by this filer
29 other filings in the data moat
Short Interest
—
Not in latest FINRA snapshot

Other 13D/G Filings on ENZO BIOCHEM INC

FiledFormFilerStakeShares
2023-07-24 SC LABORATORY CORP OF AMERICA HOLDINGS — — view →
2023-01-23 SC Wolf James G. — — view →
2022-10-26 SC Wolf James G. — — view →
2022-01-04 SC Radoff Bradley Louis — — view →
2021-12-27 SC Radoff Bradley Louis — — view →
2021-11-15 SC Wolf James G. — — view →
2021-10-22 SC Radoff Bradley Louis — — view →
2021-09-30 SC Roumell Asset Management, LLC — — view →
2021-05-05 SC Roumell Asset Management, LLC — — view →
2021-03-17 SC Harbert Discovery Fund, LP — — view →
2021-01-15 SC Roumell Asset Management, LLC — — view →
2021-01-05 SC Roumell Asset Management, LLC — — view →
2021-01-04 SC Harbert Discovery Fund, LP — — view →
2020-12-22 SC Roumell Asset Management, LLC — — view →
2020-12-21 SC Roumell Asset Management, LLC — — view →
2020-12-18 SC Roumell Asset Management, LLC — — view →
2020-12-15 SC Harbert Discovery Fund, LP — — view →
2020-12-14 SC Roumell Asset Management, LLC — — view →
2020-12-08 SC Roumell Asset Management, LLC — — view →
2020-12-07 SC Roumell Asset Management, LLC — — view →
Showing 20 of 27

Other Filings by Radoff Bradley Louis

FiledFormIssuerStakeShares
2026-10-23 SCHEDULE 13D/A INVE Technologies, Inc. 6.70% 0 view →
2026-08-24 SCHEDULE 13D/A HARTE HANKS INC — 423,447 view →
2026-08-03 SCHEDULE 13D/A GENESCO INC — 480,000 view →
2026-06-10 SCHEDULE 13D/A GENESCO INC GCO — 460,000 view →
2025-07-01 SCHEDULE Identiv, Inc. INVE 7.30% 1,727,000 view →
2025-03-18 SCHEDULE Alto Ingredients, Inc. ALTO 4.70% 3,625,000 view →
2024-10-25 SC Rocky Mountain Chocolate Factory, Inc. RMCF — — view →
2024-10-08 SC Rocky Mountain Chocolate Factory, Inc. RMCF — — view →
2024-01-11 SC EMCORE CORP — — view →
2023-10-04 SC NEWPARK RESOURCES INC NPKI — — view →
2023-08-11 SC Lifevantage Corp LFVN — — view →
2023-02-28 SC VirnetX Holding Corp VHC — — view →
2022-08-17 SC HARTE HANKS INC HHS — — view →
2022-07-06 SC NEWPARK RESOURCES INC NPKI — — view →
2022-07-06 SC Rocky Mountain Chocolate Factory, Inc. RMCF — — view →
2022-05-31 SC TRECORA RESOURCES — — view →
2022-03-14 SC TRECORA RESOURCES — — view →
2022-02-22 SC NEWPARK RESOURCES INC NPKI — — view →
2022-01-04 SC ENZO BIOCHEM INC — — view →
2021-12-27 SC ENZO BIOCHEM INC — — view →
Showing 20 of 29

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →